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Oxidative Stress Accumulates in Adipose Tissue during
Aging and Inhibits Adipogenesis
Hannes M. Findeisen1, Kevin J. Pearson2, Florence Gizard1, Yue Zhao1,2, Hua Qing1, Karrie L. Jones1,
Dianne Cohn1, Elizabeth B. Heywood1, Rafael de Cabo3, Dennis Bruemmer1,2*
1 Saha Cardiovascular Research Center, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America, 2 Graduate Center for Nutritional
Sciences, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America, 3 Laboratory of Experimental Gerontology, National Institute on
Aging, National Institutes of Health, Baltimore, Maryland, United States of America

Abstract
Aging constitutes a major independent risk factor for the development of type 2 diabetes and is accompanied by insulin
resistance and adipose tissue dysfunction. One of the most important factors implicitly linked to aging and age-related
chronic diseases is the accumulation of oxidative stress. However, the effect of increased oxidative stress on adipose tissue
biology remains elusive. In this study, we demonstrate that aging in mice results in a loss of fat mass and the accumulation
of oxidative stress in adipose tissue. In vitro, increased oxidative stress through glutathione depletion inhibits preadipocyte
differentiation. This inhibition of adipogenesis is at least in part the result of reduced cell proliferation and an inhibition of
G1RS-phase transition during the initial mitotic clonal expansion of the adipocyte differentiation process. While
phosphorylation of the retinoblastoma protein (Rb) by cyclin/cdk complexes remains unaffected, oxidative stress decreases
the expression of S-phase genes downstream of Rb. This silencing of S phase gene expression by increased oxidative stress
is mediated through a transcriptional mechanism involving the inhibition of E2F recruitment and transactivation of its target
promoters. Collectively, these data demonstrate a previously unrecognized role of oxidative stress in the regulation of
adipogenesis which may contribute to age-associated adipose tissue dysfunction.
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subcutaneous fat depot size is thought to be due to altered
replication and differentiation of preadipocytes [15,16,17,18]. The
consequence of this adipose tissue dysfunction is the redistribution of
fat from subcutaneous depots not only to intra-abdominal visceral
depots but also to ectopic sites including muscle and liver
[19,20,21]. Since impaired adipogenesis and ectopic lipid accumulation are closely related to insulin resistance [22,23], a deterioration
of adipose tissue function with aging is likely to contribute to
impaired glucose homeostasis. However, the mechanisms governing
age-related adipose tissue dysfunction and the limited regenerative
capacity of adipose tissue remain to be elucidated.
One of the key hypotheses postulated as the cause for both
organismal aging and age-related chronic diseases is the
accumulation of oxidative stress [24]. Reactive oxygen species
(ROS) accumulating over a lifetime can inflict direct cellular
damage and influence various signaling pathways and transcriptional programs regulating key development processes including
proliferation, differentiation, senescence, and apoptosis [25]. In
addition to the accumulation of oxidative damage during a life
span, aging is directly associated with an impaired antioxidant
defense mechanism. For example, levels of glutathione (GSH), one
of the most important cellular antioxidant defense mechanisms,
decline during aging in humans and mice, accompanied by
various age-related pathologies [26,27,28,29]. Although increased

Introduction
The prevalence of type 2 diabetes is increasing annually, which
is thought to be due to physical inactivity, obesity, population
growth, and aging [1,2]. In particular the increased prevalence of
obesity has been recognized as a major risk factor for type 2
diabetes [3]. However, according to recent estimates, the number
of patients with type 2 diabetes will more than double by 2030,
even if the prevalence of obesity remains constant [4]. Currently
more than half of the 20 million U.S. adults with type 2 diabetes
are above age 60, and the largest increase in type 2 diabetes
prevalence is expected in the elderly [1,5,6]. Considering this
evidence, it has been estimated that by 2050 there will be an
additional 18 million people with type 2 diabetes in the U.S. alone
as a result of increased longevity [7].
While the mechanisms underlying the relationship between
obesity and type 2 diabetes are beginning to emerge [8,9], the link
between aging and type 2 diabetes remains elusive. A decline in
glucose tolerance as part of human aging was first noted in 1921
[10], and diminished insulin sensitivity is now recognized as a
primary cause of the age-related impairment in glucose metabolism
[11,12]. One of the hallmarks of both physiological aging and
genetic forms of premature aging is the loss of insulin sensitive
subcutaneous adipose tissue [13,14]. This age-related decline in
PLoS ONE | www.plosone.org
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was homogenized by sonication with or without the thiolscavenging reagent 1-methyl-2-vinylpyridinium trifluoromethanesulfonate (M2VP). Samples were deproteinized with an equal
volume of 10% metaphosphoric acid, centrifuged, and the
supernatant was analyzed for GSH and GSSG concentrations
using a spectrophotometer at 412 nm over 3 min. Concentrations
were calculated by comparison to GSSG standards and normalized to protein content. GSH/GSSG-ratio was calculated using
the following formula: (total GSH – 2GSSG)/GSSG.

ROS production has been documented in adipose tissue of
premature aging syndromes [30] and is associated with altered
glucose homeostasis [31], it remains unknown whether oxidative
stress accumulates during physiologic aging and alters adipose
tissue biology.
In the present study, we demonstrate that aging in mice results
in a loss of adipose tissue mass and the accumulation of oxidative
stress. We further establish that increased oxidative stress inhibits
the differentiation of preadipocytes by preventing their mitotic
clonal expansion and entry into S-phase of the cell cycle. The
molecular mechanism underlying this inhibition of cell cycle
progression by oxidative stress involves a transcriptional repression
of E2F target genes.

Oil red O staining
On day 7 of differentiation cells were washed with PBS and
fixed for 10 min in 10% formalin. Oil-red-O (0.5% in isopropanol)
was diluted with water (3:2), filtered, and incubated with fixed cells
for 2 h at room temperature. Cells were washed, and Oil-red-O
was extracted with isopropanol for quantification using a
spectrophotometer at 510 nm.

Materials and Methods
Ethics statement
All procedures were performed in accordance with approved
institutional protocols and were approved by the Institutional
Animal Care and Use Committee of the National Institute on Aging
(277-LEG-2010) and the University of Kentucky (00767M2004).

Cell cycle analysis
Twenty four hours after initiation of differentiation cells were
fixed for 30 min in ice cold 70% ethanol. Cells were centrifuged
and resuspended in PBS supplemented with 40 mg/ml RNase.
After incubation for 30 min at 37uC cells were centrifuged again
and resuspended in PBS containing 50 mg/ml propidium iodide.
Cell cycle distribution was analyzed by FACS using a FACSCalibur sorting system (Becton Dickinson).

Cell culture
3T3-L1 preadipocytes (ZenBio) were maintained in DMEM
supplemented with 10% newborn calf serum. Cell differentiation
was induced using a standard protocol [32]. Briefly, two-day post
confluent cells were treated with 1 mM dexamethasone, 0.5 mM
Isobutylmethylxanthine, 10 mg/ml insulin and 10% fetal bovine
serum (FBS) for two days, followed by treatment with 10% FBS
and insulin for two additional days. Finally, the medium
supplemented with 10% FBS was renewed every other day. Lbuthionine-(S,R)-sulfoximine (BSO, Sigma) was dissolved in
diH2O and filtered before use in cell culture. Cells were treated
with BSO after reaching confluence to day 2 or day 7 of
differentiation, as indicated.

Cell proliferation assays
To measure the proliferative capacity of preadipocytes during
the mitotic clonal expansion cells were counted at day 0 and day 3
of the differentiation process using a hemocytometer. In addition,
proliferation was assessed by analyzing cell division using 5(6)carboxyfluorescein diacetate N-succinimidyl ester (CFSE). Two
day confluent cells were stained with 0.5 mM/l CFSE for 10 min
at 37uC and washed in PBS. One cell plate was immediately fixed
in 10% formalin and stored in 80% ethanol until FACS analysis to
determine the baseline fluorescence. The remaining cells were
subjected to the differentiation protocol and analyzed for CFSE
content after three days by FACS [33].

Isolation and differentiation of stromal vascular cells from
subcutaneous adipose tissue
Subcutaneous inguinal white adipose tissue was isolated from
eight week old C57BL/6 mice, pooled, and minced in HEPESbuffered DMEM (Invitrogen) supplemented with 10 mg/ml fatty
acid poor BSA (Sigma). Samples were incubated for 60 min with
0.03 mg/ml Liberase 3 (Roche) at 37uC on an orbital shaker. The
solution was passed through a sterile 100 mm nylon mesh and
centrifuged at 500 g for 10 min. The cell pellet was resuspended in
5 ml erythrocyte lysis buffer, incubated for 5 min at room
temperature, and centrifuged at 500 g for 5 min. Cells were
resuspended in DMEM with 10% fetal bovine serum, counted, and
plated on 12-well plates at a density of 16105 cells/well. Two days
after reaching confluence, cells were differentiated using adipocyte
basal medium (ZenBio) and a standard differentiation protocol.

RNA isolation and quantitative real-time RT-PCR
RNA was isolated and reverse transcribed as described [34].
Quantitative real-time PCR analysis of target gene expression was
performed using an iCycler and SYBR Green I system (Bio-Rad)
as described [34]. Each sample was analyzed in triplicate and
normalized to mRNA expression of the house-keeping gene
TFIIB. The following primer sequences were used: MCM7
(forward: 59-TGTGGGGCAGAGACCTAC-39 and reverse: 59CTGGGCAATCCTTGTGTT-39), cyclin A2 (forward: 59-CGCAGCAGAAGCTCAAGAC-39 and reverse: 59-CTTGCTGCGGGTAAAGAGAC-39), aP-2 (forward: 59-GGCCAAGCCCAACATGATC-39 and reverse: 59-CACGCCCAGTTTGAAGGAAA39) and TFIIB (forward: 59 -CTCTCCCAAGAGTCACATGTCC-39 and reverse: 59-CAATAACTCGGTCCCCTACAAC-39).

Detection of oxidative stress
Twenty four hours after initiation of differentiation cells were
washed twice with PBS and incubated with 10 mM 29,79dichlorofluorescin diacetate (H2DCFDA) for 30 min at 37uC. Cells
were washed again with PBS and collected for FACS analysis. Cells
were analyzed at excitation/emission wavelengths of 488/525 nm
using a FACSCalibur sorting system (Becton Dickinson).

Western blotting
Western Blotting was performed as described previously [35]
using the following antibodies: p21 ab7960 (Abcam), p27Kip1
ab7961 (Abcam), MCM7 sc-9966 (Santa Cruz), CyclinA ab38
(Abcam), GAPDH sc-25778 (Santa Cruz), Phospho-Rb (Ser807/
811) 9308S (Cell Signaling), E2F1 sc-193 (Santa Cruz).

GSH/GSSG-assay
GSH/GSSG-ratio was analyzed in epididymal adipose tissue
using the Bioxytech GSH/GSSG-412 kit (Oxis Research). Tissue
PLoS ONE | www.plosone.org
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stromal vascular cells were stimulated with standard differentiation
medium. Cells were harvested at the indicated time points and
soluble chromatin was prepared. Chromatin was immunoprecipitated using an antibody (5 mg) directed against E2F-1 (sc-193X,
Santa Cruz) or control IgG (provided in the ChIP-kit). Final DNA
extractions were PCR-amplified using the following primer pairs
that cover the E2F-1 consensus site in the MCM7-promoter:
forward: 59-CGCTTTAAGAAACACTCCTCCCACAC-39 and
reverse: 59-GCCAGCCCCTAACTTTAACCAATCAATG-39.

Transient transfections
3T3-L1 preadipocytes were seeded in 6-well plates and
transfected two days after reaching confluence. Transient
transfections were performed using Lipofectamine 2000 (Invitrogen) and 1.5 mg DNA of a luciferase reporter plasmid driven by
the full length MCM7 promoter [36]. Transfection efficiency was
normalized to renilla luciferase activities generated by cotransfection with 1.5 ng/well pRL-CMV (Promega). After 4 h the
medium was changed to standard differentiation medium.
Luciferase activity was assayed 24 h after initiation of differentiation using a Dual Luciferase Reporter Assay System (Promega).

Aging cohort
Male C57BL/6 mice were obtained from The Jackson Laboratory
at 6 weeks of age and allowed to age normally at the National
Institute on Aging in Baltimore, MD according to approved animal
protocols and NIH guidelines. The mice were housed in an

Chromatin immunoprecipitation assays
Chromatin immunoprecipitation (ChIP) assays were performed
using the Magnify-ChIP-System (Invitrogen). Two day confluent

Figure 1. Aging is associated with decreased fat mass and increased oxidative stress in mice. A-C: Body weight and body composition
were analyzed in C57BL/6 mice fed a regular chow diet at the indicated age (n = 10 for each age group except n = 9 and 8 for 24 and 29 month,
respectively, due to differences in longevity). D: GSH/GSSG-ratio was measured in epididymal adipose tissue of 2 month (n = 7) and 26-month old
(n = 5) mice. All results are presented as mean 6 SEM (* p,0.05 vs. 12 month in A–C or 2 month in D).
doi:10.1371/journal.pone.0018532.g001
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nuclear magnetic resonance using the Minispec LF90 (Bruker
Optics).

environmentally-controlled vivarium maintained between 68–72uF
with unlimited access to food (Diet 2018; Harlan Teklad) and water
under a controlled photoperiod (12 hr light; 12 hr dark).

Statistics
Body composition

ANOVAs using one-way or two-way ANOVA with Bonferroni’s t test for post hoc analysis and paired or unpaired t test were
performed for statistical analysis as appropriate. Data were

Measurements of fat mass in C57BL/6 mice aged 2.5–29
months were acquired as part of a cross-sectional study by

Figure 2. BSO treatment inhibits adipogenesis. A and B: Confluent 3T3-L1 cells were treated with different doses of BSO for 2 days and induced
to differentiate. BSO treatment was continued until day 7 of differentiation. Differentiated cells were stained with Oil-red-O and absorbance was
measured at 510 nm using a spectrophotometer. C: Confluent 3T3-L1 cells were treated with 100 mM BSO for 2 days and induced to differentiate.
BSO treatment was continued until day 7 of differentiation. On day 7 mRNA was harvested and aP-2 expression was analyzed by real-time RT-PCR. D:
Confluent subcutaneous stromal vascular cells were treated with 10 mM BSO. After 2 days cells were induced to differentiate and treated with BSO
until day 7 of differentiation. On day 7 mRNA was harvested and aP-2 expression was analyzed. E: 3T3-L1 cells were treated with 100 mM BSO for 2
days and induced to differentiate. BSO treatment was continued until day 2 or day 7 of differentiation as indicated. On day 7 cells were stained with
Oil-red-O and absorbance was measured. All results are presented as mean 6 SEM (* p,0.05 vs. control).
doi:10.1371/journal.pone.0018532.g002
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reported as means 6 SEM. P values ,0.05 were considered
statistically significant.

expression of the adipocyte marker aP-2 after 7 days of
differentiation in 3T3-L1 preadipocytes (Figure 2C). Similar
results were observed in murine preadipocytes derived from the
stromal vascular fraction of inguinal (Figure 2D) as well as
epididymal fat pads (data not shown) indicating that the observed
inhibition of adipocyte differentiation is also applicable to primary
preadipocytes. Due to their significantly higher differentiation
capacity in vitro, further experiments in primary preadipocytes
were performed in SVC of subcutaneous depots. Quantification of
Oil-red-O-staining further revealed a comparable inhibition of
adipocyte differentiation in 3T3-L1 preadipocytes exposed to BSO
treatment either continuously until day 7 or only until day 2 of
differentiation (Figure 2E). These results indicate that the
inhibition of adipogenesis by BSO occurs at least in part during
the initial phase of differentiation, which represents the mitotic
clonal expansion phase required for preadipocyte differentiation.

Results
Aging in mice results in a loss of fat mass and increased
oxidative stress in adipose tissue
To determine whether aging is associated with changes in body
mass and composition, we first followed weight and fat mass in
aging C57BL/6 mice. As depicted in Figure 1A, after an initial
increase in body weight during the first year there was a
continuous decline in body mass in the second and third year of
life. Analysis of body composition revealed that this decline in
body mass was primarily due to a loss of fat mass (Figure 1B–C).
At 29 months of age, the fat mass of C57BL/6 mice was reduced
to approximately 30% of the peak fat mass at 12 months of age.
Since oxidative damage constitutes one of the most studied
hallmarks of aging and is implicitly linked with age-related disease,
we next analyzed whether aging results in increased oxidative
stress in adipose tissue. As shown in Figure 1D, the ratio of
reduced to oxidized glutathione in adipose tissue decreases
significantly in 26-month old mice, representing a shift to
increased oxidation.

Glutathione depletion induces oxidative stress
To document specificity of the BSO compound with respect to
increased oxidative stress and glutathione depletion, we next
measured intracellular ROS levels in 3T3-L1 adipocytes using
H2DCF-DA. As expected, BSO treatment increased ROS levels
by 6-fold 24 h after the induction of differentiation (Figure 3A).
Furthermore, reconstitution of glutathione levels in BSO-treated
3T3-L1 cells by providing glutathione-ethylester was sufficient to
improve the adipogenic capacity (Figure 3B). These data confirm
specificity of BSO treatment and demonstrate that glutathione
depletion increases oxidative stress in adipocytes and inhibits
adipogenesis.

Oxidative stress inhibits adipogenesis in 3T3-L1
preadipocytes and stromal vascular cells
Based on the observation that aging is associated with a decline
in fat mass and a concomitant increase in oxidative stress, we next
analyzed whether oxidative stress affects adipogenesis. The GSHdependent ROS scavenging network represents one of the key host
defense mechanisms against oxidative stress [27]. Oxidative stress
in conjunction with GSH depletion is associated with various
diseases and can be achieved pharmacologically to increase
endogenously produced oxidative stress using BSO, a specific
and irreversible inhibitor of glutamate cysteine ligase [37]. As
depicted in Fig. 2A and B, glutathione depletion using BSO
significantly inhibited the differentiation of post-confluent 3T3-L1
preadipocytes. Correspondingly, BSO treatment reduced mRNA

Oxidative stress inhibits the mitotic clonal expansion
The observation that oxidative stress inhibits adipocyte
differentiation during the first two days of the differentiation
process pointed to an inhibition of the mitotic clonal expansion, a
prerequisite for adipocyte differentiation. Consistent with this
notion, the mitotic expansion of 3T3-L1 preadipocytes following
induction of differentiation was significantly decreased by BSO
treatment (Figure 4A). To further corroborate that BSO inhibits

Figure 3. Glutathione depletion induces intracellular ROS formation during differentiation. A: Confluent 3T3-L1 cells were treated with
100 mM BSO. After 2 days BSO treatment was renewed and cells were induced to differentiate. 24 h after hormonal induction cells were incubated
with 10 mM H2DCFDA and analyzed by FACS. B: Confluent 3T3-L1 cells were treated with 100 mM BSO until day 2 of differentiation. 5 mM GSH-ester
was added one day prior to differentiation. On day 7 of differentiation cells were stained with Oil-red-O and analyzed using a spectrophotometer. All
results are presented as mean 6 SEM (* p,0.05 vs. control, # p,0.05 vs. BSO).
doi:10.1371/journal.pone.0018532.g003
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mitosis of preadipocytes we followed proliferation rates using
CFSE labeling, a dye that is inherited equally by daughter cells
after division, resulting in the sequential halving of fluorescence
with each generation. As depicted in Figure 4B, BSO treated cells
exhibited considerably reduced cell division rates evidenced by an

increased retention of fluorescence. FACS analysis further
revealed that oxidative stress inhibited S phase entry during the
mitotic clonal expansion and resulted in an increased number of
cells arrested in the G0/G1 phase (Figure 4C). Similarly, BSO
treatment of stromal vascular cells inhibited cell cycle progression

Figure 4. BSO treatment inhibits mitotic clonal expansion. A: Confluent 3T3-L1 cells were treated with 100 mM BSO. After 2 days cells were
induced to differentiate. BSO treatment was renewed with every change of medium. Cells were counted at induction and at day 3 of differentiation
using a hemocytometer. Cell number did not differ at induction of differentiation. B: Confluent cells were treated with 100 mM BSO for two days. Cells
were labeled with CFSE and induced to differentiate. BSO treatment was renewed with every change of medium. On day 3 of differentiation cells
were collected and analyzed using FACS. CFSE mean fluorescence declines with cell division, and geometric mean fluorescence is inversely
proportional to the proliferation rate. C: Cells were treated as described in A. 24 h after induction of differentiation cell cycle distribution was assessed
by DNA staining with propidium iodide and subsequent FACS analysis. Cell cycle distribution did not differ at induction of differentiation (baseline).
D: Confluent subcutaneous stromal vascular cells were treated with 10 mM BSO. After 2 days, BSO treatment was renewed and cells were induced to
differentiate. Cell cycle distribution was analyzed after 16 h. All results are presented as mean 6 SEM (* p,0.05 vs. control).
doi:10.1371/journal.pone.0018532.g004
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phase of mitotic clonal expression the phosphorylation of Rb was
induced; however, this phosphorylation step was not modulated by
BSO (Figure 5B). Furthermore, BSO did not alter the induction of
E2F1 expression during mitotic clonal expansion (Figure 5C). In
contrast, the induction of the downstream S phase E2F target
genes cyclin A and MCM7 was considerably reduced at both
protein and mRNA expression levels in preadipocytes treated with
BSO (Figure 5D–F).

(Figure 4D). In concert, these data indicate that oxidative stress
inhibits adipocyte differentiation by blocking the mitotic clonal
expansion and cell cycle progression.

BSO treatment results in down-regulation of E2F target
genes during mitotic clonal expansion
G1RS phase transition requires phosphorylation of the
retinoblastoma protein (Rb) resulting in the transactivation of S
phase target genes by the transcription factor E2F [38]. Rb
phosphorylation is induced by the formation of cyclin and cyclindependent kinase (CDK) complexes and repressed by association
with negative regulatory subunits, the CDK inhibitors (CDKI)
[39]. As shown in Figure 5A, mitotic clonal expansion during
differentiation was associated with a decline in p27Kip1 protein
levels, and neither the degradation of p27Kip1 nor p21 protein
levels were affected by increased oxidative stress. During the initial

Oxidative stress alters the E2F-dependent transactivation
of the MCM7 target promoter
To further determine the mechanisms underlying the altered
transcription of the bona fide E2F target genes cyclin A and MCM7
by oxidative stress, we next analyzed the promoter activity of these
two genes. Exemplified for the MCM7 promoter in Figure 6A, BSO
treatment profoundly decreased the activity of a luciferase reporter

Figure 5. BSO treatment decreases E2F target gene expression. A to D: Confluent 3T3-L1 cells were treated with 100 mM BSO. After 2 days
cells were induced to differentiate. BSO treatment was renewed with every change of medium. Whole cell lysate was collected at the indicated time
points and analyzed for protein expression of p21, p27, phosphorylated Rb, E2F1, cyclin A, MCM7, and GAPDH. E and F: 3T3-L1 cells were treated as
described in A. mRNA was harvested at induction of differentiation and at day 1 of differentiation. MCM7 and cyclin A2 expression was analyzed by
real-time RT-PCR. All results are presented as mean 6 SEM (* p,0.05 vs. control, # p,0.05 vs. baseline).
doi:10.1371/journal.pone.0018532.g005
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driven by the MCM7 promoter. Furthermore, ChIP assays
demonstrated that oxidative stress altered the induction of E2F
binding to its consensus site in the MCM7 promoter during the
early differentiation process (Figure 6B). Collectively, these data
indicate that the inhibition of cell cycle transition by oxidative stress
is at least in part the result of an altered transactivation and
transcriptional silencing of E2F target genes.

Aged adipose tissue displays reduced expression of E2F
target genes and adipocyte differentiation markers
We next analyzed E2F target gene expression in adipose tissue
of young and old mice that displayed an accumulation of oxidative
stress during aging. As depicted in Figure 7A and B, aging was
associated with a significant decline in the expression of cyclin A
and MCM7 in epididymal adipose tissue. Furthermore, this
decrease in E2F target gene expression was accompanied by a
decrease in transcript levels of the adipocyte differentiation marker
aP-2 (Figure 7C). These data demonstrate similar alterations in
gene expression between aged adipose tissue and BSO treated
3T3-L1 preadipocytes.

Discussion
Oxidative damage is postulated to be a key mechanism involved
in organismal aging [24]. While oxidative stress accumulates in
adipose tissue and has been implicated in insulin resistance [31],
the inherent mechanisms linking oxidative damage to adipose
tissue dysfunction remain unknown. In the present study, we
demonstrate that aging of mice is associated with a decline in fat
mass and the accumulation of oxidative stress. We further establish
that oxidative stress through glutathione depletion alters adipocyte
differentiation by inhibiting the mitotic clonal expansion. In
concert, these data may provide a previously unrecognized
mechanism contributing to age-related adipose tissue dysfunction.
Using longitudinal NMR analysis our studies documented an
age-related decline of fat mass in mice, a finding that is
consistent with a prior study [40]. We further demonstrate for
the first time that this age-related loss of adipose tissue mass is
associated with the accumulation of oxidative stress. Considering both observations and the well-established inhibition of
progenitor proliferation and differentiation by oxidative damage
[25], we hypothesized a causal relationship and tested whether
oxidative stress alters adipogenesis. Our approach to induce
oxidative stress employed the depletion of glutathione, a
sophisticated non-enzymatic antioxidant defense system, allowing the accumulation of endogenously generated ROS [27].
Increased oxidative stress generated through glutathione
depletion inhibited adipocyte differentiation of 3T3-L1 fibroblasts and primary stromal vascular cell fractions. Since
adipocyte differentiation involves a chronologically regulated
and complex network of cell cycle regulators and adipogenic
transcription factors [41], we investigated the stage at which
oxidative stress affects this differentiation process. Interestingly,
cells treated with BSO for only the first two days of
differentiation exhibited an almost similar inhibition of adipogenesis as cells treated for the entire seven days of differentiation. This first phase of differentiation is characterized by the
progression of preadipocytes through one or two cell cycle
divisions, referred to as mitotic clonal expansion [41]. Since
glutathione depletion potently inhibited preadipocyte proliferation, these observations indicate that oxidative stress inhibits
adipocyte differentiation at least in part by blocking their
mitotic clonal expansion. Considering further that aging impairs
the replicative potential of preadipocytes and their differentiaPLoS ONE | www.plosone.org

Figure 6. Oxidative stress alters E2F-dependent transactivation
of the MCM7 promoter. A: 3T3-L1 cells were treated with 100 mM BSO.
After 2 days cells were transfected with a MCM7 promoter luciferase
reporter plasmid. Following transfection, cells were induced to differentiate and BSO treatment was renewed. Luciferase activity was assayed
24 h after initiation of differentiation. Transfection efficiency was
adjusted by normalizing firefly luciferase activities to renilla luciferase
activities generated by cotransfection with pRL-CMV. B: Confluent
subcutaneous stromal vascular cells were treated with 10 mM BSO. After
2 days BSO treatment was renewed and cells induced to differentiate.
Cells were collected at indicated time points for ChIP assays. After
chromatin immunoprecipitation with an E2F antibody or control IgG,
quantitative real-time RT-PCR analysis was performed with primer pairs
covering the E2F-binding site in the MCM7 promoter. All results are
presented as mean 6 SEM (* p,0.05 vs. control, # p,0.05 vs. baseline).
doi:10.1371/journal.pone.0018532.g006

tion capacity [15,16,17,18], we would infer that oxidative stress
constitutes a possible mechanism underlying age-related adipose
tissue dysfunction.
The mechanism by which glutathione depletion in 3T3-L1
cells inhibited mitotic expansion involved an inhibition of cell
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cycle progression at the G1RS-phase transition. Progression
through the S phase is governed by the phosphorylation of Rb,
which releases the repression of E2F target genes allowing
transcription of S phase genes [38]. Oxidative stress exhibited no
effect on the upstream CDKI or on the phosphorylation of Rb by
cyclin/CDK complexes. However, the expression and transcriptional activation of the downstream E2F target genes cyclin A
and MCM7 were significantly reduced in BSO-treated 3T3-L1
cells. Similarly, increased oxidative stress in adipose tissue of aged
mice was accompanied by decreased expression of cyclin A and
MCM7. These experiments indicate that oxidative stress alters
the ability of E2F to transactivate its target genes, independently
of Rb phosphorylation. This concept is supported by a recent
study demonstrating that stress signals interfere with the E2Fdependent transactivation of genes required for S phase
progression [42]. Although the detailed transcriptional mechanisms responsible for the silencing of E2F target genes remain
unknown, it is possible that epigenetic modifications induce a
transcriptionally inert chromatin environment, considering the
widespread epigenetic changes occurring in response to oxidative
damage [43]. Alternatively, E2F transcriptional activity may be
repressed through negative cross-talk with other transcription
factors. For example, oxidative stress is well established to
activate inflammatory signaling, and Akari et al. recently
demonstrated that NF-kB signaling represses E2F transcription
factors [44]. Another group of transcription factors which may
modulate E2F binding activities during adipogenesis are DP
(DRTF1 polypeptide) proteins [45]. In particular, oxidative stress
could potentially inhibit DP protein expression levels or its
posttranslational modification, which could repress the binding
activity of its heterodimeric partner E2F. Finally, Fajas et al.
revealed that E2F1 deficiency in mice inhibits adipogenesis [46],
lending further compelling support for a key role of E2F in the
control of adipogenesis in vivo.
Several prior studies have established an important role of
glutathione-dependent oxidative stress in adipose tissue function
and metabolism in vivo. Consistent with our observations, a recent
study by Loh et al. reported that genetic deficiency of glutathione
peroxidase 1 increased reactive oxygen species and decreased fat
mass expansion following high fat diet feeding [47]. Similarly,
pharmacologic glutathione depletion in rats treated with BSO
resulted in decreased body weight and altered insulin-stimulated
glucose uptake in adipose tissue [48,49]. However, since fat mass
was not analyzed in this report, further studies on the effect of
oxidative stress on energy balance and metabolism are warranted.
Nevertheless, the decreased body weight in response to BSO
combined with the associated adipose tissue insulin resistance
noted in this study point to an important role of oxidative stress in
adipose tissue biology and metabolism. This notion is further
supported by studies in humans demonstrating that reduced
glutathione infusion increases insulin sensitivity [50], providing
further confirmation that oxidative stress alters insulin sensitivity.
Considering this literature and our findings in concert, it appears
conceivable to speculate that the inhibition of adipogenesis by
oxidative stress may constitute an important contributor to the loss
of adipose tissue mass during aging. However, further studies are
warranted to confirm this hypothesis and to define the
mechanisms underlying the development of insulin resistance in
response to aging.
Figure 7. Aged adipose tissue displays reduced expression of E2F
target genes and adipocyte differentiation markers. A to C: mRNA
was isolated from epididymal adipose tissue of 4 and 26 month old male
C57BL/6 mice. Expression of cyclin A, MCM7 and aP-2 was analyzed by realtime RT-PCR. All results are presented as mean 6 SEM (* p,0.05 vs. control).
doi:10.1371/journal.pone.0018532.g007
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